Last reviewed · How we verify
Product 1 - AquaCelle Fish Oil Triglyceride
Product 1 - AquaCelle Fish Oil Triglyceride is a Small molecule drug developed by RDC Clinical Pty Ltd. It is currently FDA-approved.
At a glance
| Generic name | Product 1 - AquaCelle Fish Oil Triglyceride |
|---|---|
| Sponsor | RDC Clinical Pty Ltd |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Product 1 - AquaCelle Fish Oil Triglyceride CI brief — competitive landscape report
- Product 1 - AquaCelle Fish Oil Triglyceride updates RSS · CI watch RSS
- RDC Clinical Pty Ltd portfolio CI
Frequently asked questions about Product 1 - AquaCelle Fish Oil Triglyceride
What is Product 1 - AquaCelle Fish Oil Triglyceride?
Product 1 - AquaCelle Fish Oil Triglyceride is a Small molecule drug developed by RDC Clinical Pty Ltd.
Who makes Product 1 - AquaCelle Fish Oil Triglyceride?
Product 1 - AquaCelle Fish Oil Triglyceride is developed and marketed by RDC Clinical Pty Ltd (see full RDC Clinical Pty Ltd pipeline at /company/rdc-clinical-pty-ltd).
What development phase is Product 1 - AquaCelle Fish Oil Triglyceride in?
Product 1 - AquaCelle Fish Oil Triglyceride is FDA-approved (marketed).